EPD Biotherapeutics

Developing innovative therapies with Engineered Protein Degraders.

Launch date

Aug 2021

Employees

Market cap

Enterprise valuation

Company register number 3108134482

Seoul South Korea (HQ)

http://www.epdbio.com/

https://www.linkedin.com/company/epd-biotherapeutics-inc/

Revenues, earnings & profits over time

USD	2022	2023
Revenues	<1m	<1m
% growth	-	50 %

Date	Investors	Amount	Round
Oct 2021*	N/A	KRW500m	Seed
Jun 2022*	Mirae Asset Venture Investment FuturePlay Hana Ventures Medytox Venture Investment	KRW4.4b	Seed
Jan 2023*	Hana Ventures	N/A	-
Jul 2024*	Genexine	$180m	Acquisition
Total Funding		€3.7m